Followers | 104 |
Posts | 2500 |
Boards Moderated | 0 |
Alias Born | 12/02/2016 |
Sunday, September 10, 2017 4:17:28 PM
I have perused the latest TXTM quarterly report from August 21st, and according to the information found within, we observe that Steve Berman (the current CEO of ONC-I) continues to hold a stake in his former company, Protext Pharma/Mobility.
https://www.otcmarkets.com/financialReportViewersymbol=TXTM&id=177897
According to this filing, Steve Berman maintains beneficial ownership of 2,675,000 Series C Preferred shares. It is also stated that Series C Preferred shares are endowed voting rights equal to 200 votes per each share on all shareholder matters.
As you have alluded, Berman has announced his interest to pursue MJ/Cannabis projects. It is speculative whether Protext will be involved in such future projects, but what does remain clear, is that Berman is most certainly still connected to Protext, as the below information demonstrates.
Avant Technologies Engages Wired4Tech to Evaluate the Performance of Next Generation AI Server Technology • AVAI • May 23, 2024 8:00 AM
Branded Legacy, Inc. Unveils Collaboration with Celebrity Tattoo Artist Kat Tat for New Tattoo Aftercare Product • BLEG • May 22, 2024 8:30 AM
"Defo's Morning Briefing" Set to Debut for "GreenliteTV" • GRNL • May 21, 2024 2:28 PM
North Bay Resources Announces 50/50 JV at Fran Gold Project, British Columbia; Initiates NI 43-101 Resources Estimate and Bulk Sample • NBRI • May 21, 2024 9:07 AM
Greenlite Ventures Inks Deal to Acquire No Limit Technology • GRNL • May 17, 2024 3:00 PM
Music Licensing, Inc. (OTC: SONG) Subsidiary Pro Music Rights Secures Final Judgment of $114,081.30 USD, Demonstrating Strength of Licensing Agreements • SONGD • May 17, 2024 11:00 AM